Back to Search Start Over

Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptors.

Authors :
Murineddu G
Gotti C
Asproni B
Corona P
Martinello K
Plutino S
Fucile S
Temml V
Moretti M
Viani P
Schuster D
Piras S
Deligia F
Pinna GA
Source :
European journal of medicinal chemistry [Eur J Med Chem] 2019 Oct 15; Vol. 180, pp. 51-61. Date of Electronic Publication: 2019 Jul 05.
Publication Year :
2019

Abstract

We designed the synthesis of a small library of 3-substituted-3,6-diazabicyclo[3.1.1]heptanes whose affinity on neuronal nicotinic receptors (nAChRs) was evaluated. Among the synthesized compounds, the 5-(3,6-diazabicyclo[3.1.1]heptane-3-yl)-N-(2-fluorophenyl)nicotinamide 43 proved to be the most interesting compound with α <subscript>4</subscript> β <subscript>2</subscript> Ki value of 10 pM and a very high α <subscript>7</subscript> /α <subscript>4</subscript> β <subscript>2</subscript> selectivity. Furthermore, compounds 35, 39 and 43 elicited a selective partial agonist activity for α <subscript>4</subscript> β <subscript>2</subscript> nAChR subtype. Finally, in this paper we also report the conclusions on the 3,6-diazabicyclo[3.1.1]heptanes as ligands for nAChRs, resulting from our consolidated structure activity relationship (SAR) studies on this template.<br /> (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)

Details

Language :
English
ISSN :
1768-3254
Volume :
180
Database :
MEDLINE
Journal :
European journal of medicinal chemistry
Publication Type :
Academic Journal
Accession number :
31299587
Full Text :
https://doi.org/10.1016/j.ejmech.2019.06.079